🇺🇸 FDA
Patent

US 11021515

Therapeutically active compounds and their methods of use

granted A61KA61K38/00A61K38/05

Quick answer

US patent 11021515 (Therapeutically active compounds and their methods of use) held by Agios Pharmaceuticals, Inc. expires Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Agios Pharmaceuticals, Inc.
Grant date
Tue Jun 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61K, A61K38/00, A61K38/05, A61K38/07, A61K45/06